The patient engagement model is shifting. Historically, the relationship between drug developers and patients is often viewed in commercial terms. Recently, there has been chatter of pharma, patients, and advocacy uniting to harness patient and advocacy insights and build lasting relationships. This PM360 Webcast will probe this dynamic alliance and delve into the issues that ignited the broadening dialogue and discuss the growing importance of collaborating from the onset of development to post-approval.
Webinar Access
Please complete the form below to access the webinarHosted by Paul Kidwell and Featuring:
Thomas P. Sellers, MPA
Sr. Director, Patient Advocacy & Corporate Philanthropy
Takeda Oncology
Tom Sellers is a cancer survivor. He joined Millennium in 2011 and currently manages relationships with the patient community and programs ensuring patients have information and access to treatments.
Ronny Mosston
Vice President of Patient Advocacy & Public Affairs
OvaScience
Ronny currently works for a company focused on the discovery, development,and commercialization of new fertility treatments. She has consulted biotech organizations to develop innovative, compliant, and cross-functional PatientAdvocacy strategies in all phases of the drug pipeline.
Brenda Snow
Founder & CEO
The Snow Companies
Ms. Snow is living with multiple sclerosis and has made it her life’s mission to connect people living with chronic conditions to their peers and leaders in the life science industry. As the Founder and CEO of the healthcare communication agency The Snow Companies, she is making this vision a reality.
